Lutris Pharma - Crunchbase Company Profile & Funding

Q: Where is Lutris Pharma's headquarters?

Lutris Pharma is located in Tel Aviv-yafo, Tel Aviv, Israel.

Q: Who invested in Lutris Pharma?

Lutris Pharma has 5 investors including Peregrine Ventures And Columbus Venture Partners.

Q: When was the last funding round for Lutris Pharma?

Lutris Pharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Lutris Pharma raised to date?

Lutris Pharma has raised obfuscated.

Overview

Lutris Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Lutris Pharma

CB Rank

66589

Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.

Founded

obfuscation

Private

Venture - Series Unknown

Tel Aviv-yafo, Tel Aviv, Israel

11-50

www.lutris-pharma.com

Biotechnology

First Aid

Health Care

Wellness

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Noa Shelach: Founder & CEO

Details

Operating Status

Active

Company Type

For Profit

Founders

Noa Shelach

About the Company

Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness. The company develops the topical B-Raf inhibitor LUT014, a proprietary small molecule that allows administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects.

Lutris Pharma was

established in 2015 and is based in Tel Aviv-yafo, Israel.

Predictions & Insights

Growth Insight

See this Growth Insight

Lutris Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

LUT014

A topical B-Raf inhibitor developed to reduce acneiform lesions in patients undergoing EGFR inhibitor therapy for metastatic colorectal cancer.

Radiation Dermatitis Treatment

LUT014 is also being investigated for its effectiveness in treating radiation-induced dermatitis in breast cancer patients.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lutris Pharma	4	obfuscated obfuscation	Columbus Venture Partners, Pontifax	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Peregrine Ventures	—	Venture Round - Lutris Pharma	—
Peregrine Ventures	—	Venture Round - Lutris Pharma	—
Peregrine Ventures	—	Venture Round - Lutris Pharma	—
Peregrine Ventures	—	Venture Round - Lutris Pharma	—
Peregrine Ventures	—	Venture Round - Lutris Pharma	—